Technology
Bexa is small and portable allowing exams to be performed virtually anywhere.
What makes Bexa unique?
Bexa™’s proprietary pressure sensor array is a critical component of the device and is unique, setting a standard as the original and only high-definition capacitive pressure sensor array since.
Since 2006 Bexa has continuously evolved adding improvements in accuracy and precision. Not all sensor arrays are equal, and the Bexa™ array has no peer.
The Bexa™ Process adds and fully integrates high frequency linear ultrasound (5-15 MHz) images of abnormal breast masses to create a breast examination process that has the highest sensitivity and specificity of any point of care examination, yet still only requires 15 minutes. Less than 5% of women require additional appointments and imaging studies.The Bexa™ sensor array samples breast tissue elasticity measurements over 10,000 times per second in order to define tissue detail. The unique and proprietary algorithms that process and analyze these signals were created by experts in fractional calculus, soft tissue mechanics, artificial intelligence, data analysis, and machine learning and power our ability to detect even small masses easily and in real-time.
The Bexa™ sensor array samples breast tissue elasticity measurements over 10,000 times per second in order to define tissue detail. The unique and proprietary algorithms that process and analyze these signals were created by experts in fractional calculus, soft tissue mechanics, artificial intelligence, data analysis, and machine learning and power our ability to detect even small masses easily and in real-time.
All Bexa™ elastography and ultrasound data is anonymized and automatically fed into our proprietary ML/AI engine which is continuously improving our image analysis and anomaly-detection algorithms. Even though a breast examination with Bexa™ is the most sensitive POC identification of abnormal breast tissues, we’re evolving with every woman examined.
All Bexa™ devices operate within a secure, HIPAA/HITECH-compliant, cloud-based ecosystem, SureView, which provides device management and continuous quality monitoring of examiners and devices while contributing de-identified clinical data to a unique instance of the world’s most powerful clinical research database. With SureView, enterprise and population-wide deployments can be easily monitored and managed.
Our technology
Bexa is a new, FDA-cleared 510(k) medical device that employs high resolution elastography to produce a map of abnormal breast tissues and masses.
A breast examination with Bexa is quick, painless, involves no radiation and provides women with an immediate result.
Breast examination with Bexa
BeSure uses an advanced, proprietary capacitive sensor array that collects data about abnormal tissues based upon their elastic nature – how firm they are compared to surrounding tissue. These differences in tissue firmness are captured digitally when the Bexa™ sensor array is moved gently across the surface of the breast. No radiation or energy of any kind is emitted by the sensor.
A breast examination with Bexa fully integrates the evaluation of all discovered breast masses using B-mode ultrasound, adding critical data to the evaluation and classification of abnormal breast tissues, and dramatically reducing an already low need for additional imaging studies.
